Delivery Order SPE2DB22D2206-SPE2DB24FGM11

Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $11,244.44 firm-fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a pharmaceutical product. The contract has a completion date of July 12, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $43,667.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of ABRAXANE 100 MG VIALS, with an ultimate completion date of November 7, 2024. The contract has a Firm Fixed Price pricing type and is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp for the delivery of ABRAXANE 100 mg vials, a specialty pharmaceutical product. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order with a firm fixed price of $42,197.40 and a period of performance through September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide this critical medication to support federal healthcare programs...
This federal contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The fixed-price contract, valued at $2,960.86, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract has a completion date of February 1, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY7ZM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ABRAXANE 100 MG VIALS. The contract has a ceiling value of $9,439.35 and is a firm fixed-price Delivery Order with an ultimate completion date of June 6, 2024. AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FQ1P0, is for the delivery of 4565683440 units of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The $18,089.40 firm fixed-price contract was awarded on September 4, 2024 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 5, 2024 and was not set aside for any specific business type. Amerisourcebergen holds...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,199.46 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ABRAXANE 100 MG vials. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp holds several other indefinite delivery contracts with DLA and the Department of Justice Federal Bureau of Investigation Headquarters Division to supply pharmaceuticals and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,340.40 firm fixed-price delivery order is for the supply of ABRYSVO vials with diluent syringes, a medical product used in federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,014.72 firm fixed price delivery order is for the supply of DOXIL 20 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FGM11
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $20,776.50 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. This award does not have a set-aside designation.

The contract is associated with a larger indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 with a performance period through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceuticals and medical supplies to support military treatment programs and facilities worldwide. In addition to the DLA IDC, Amerisourcebergen Drug Corp holds a separate indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division, valued at up to $750,000 through May 2024, for the provision of medical supplies and prescription medications.

Generated 7/3/24, 9:07 AM